Whalesbook
India's drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), has extended the ceiling prices for orthopaedic implants used in knee replacements for another year, until November 15, 2026. This decision offers significant relief to patients by maintaining lower costs for knee replacement procedures. However, manufacturers had argued that continued price caps could discourage research and development in this vital segment of medical technology.